Laboratory Corporation of America(R) Schedules Second Quarter 2002 Results Conference Call

BURLINGTON, N.C., Jul 19, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) expects to release second quarter financial results at approximately 5:00 p.m. Eastern Time on July 24, 2002. A conference call has been scheduled for Thursday,

Laboratory Corporation of America(R) Signs Group Purchasing Agreement With Premier

BURLINGTON, N.C., Jul 15, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that it has signed a national contract with San Diego-based Premier, Inc., one of the country's largest group purchasing organizations.

EXACT Sciences and LabCorp(R) to Offer PreGen-Plus(TM), Changing the Health Care Landscape With Non-Invasive, Genomics-Based Colorectal Cancer Technology

MAYNARD, Mass. and BURLINGTON, N.C., Jun 27, 2002 /PRNewswire-FirstCall via COMTEX/ -- Exclusive Licensing Agreement to Make PreGen-Plus Available to a Potential Market of 80 Million Americans; Will Mark the First DNA-based Screening Method For Cancer in an Average-Risk Population EXACT Sciences

LabCorp(R) Announces Expiration of Antitrust Waiting Period In Offer for Dynacare Inc.

BURLINGTON, N.C., Jun 20, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to its offer to purchase all outstanding shares of

LabCorp(R) Scheduled to Present at the Goldman, Sachs & Company Global Health Care Conference

BURLINGTON, N.C., Jun 11, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of public affairs, is scheduled to speak at the Goldman, Sachs & Company Global Health Care

LabCorp to Co-Sponsor Educational Web Cast on Bladder Cancer Recurrence

BURLINGTON, N.C., Jun 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- LabCorp First to Offer Abbott Vysis(R) UroVysion Test for Early Detection of Recurring Bladder Cancer Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced its co-sponsorship of a landmark Web cast with

LabCorp Exclusively Offers Myriad Genetics' Predictive Medicine Products

BURLINGTON, N.C., Jun 5, 2002 /PRNewswire-FirstCall via COMTEX/ -- Physicians Can Offer Predisposition Testing for Various Cancers And Hypertension Through LabCorp's Patient Service Centers Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced the implementation of its

Laboratory Corporation of America(R) Announces Definitive Agreement to Acquire Dynacare Inc.

BURLINGTON, N.C. and DALLAS, May 9, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), a national clinical laboratory with 2001 revenues of $2.2 billion, and Dynacare Inc. (Nasdaq: DNCR; Toronto: DNA), a leading independent provider of

LabCorp(R) Scheduled To Present At The Deutsche Bank Securities Health Care Conference

BURLINGTON, N.C., May 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs, is scheduled to speak at the Deutsche Bank Securities Health Care Conference

Laboratory Corporation of America(R) Reports First Quarter 2002 Results

Double-Digit Revenue Growth Fuels 33 Percent Increase in EPS; Announces Two-For-One Stock Split BURLINGTON, N.C., April 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH)(LabCorp(R)) today announced results for the quarter ended March 31, 2002.